Advancements in Non-invasive AI-Powered Glucose Monitoring: Leveraging Multispectral Imaging Across Diverse Wavelengths
Abstract: The pursuit of non-invasive glucose monitoring has leveraged multispectral imaging technology. Our study focuses on improving GlucoCheck, a non-invasive AI-powered glucose monitor. Through processing a dataset of 3600 images, we derived four subsets for unique wavelengths and trained regression models. Performance evaluations, employing Mean Absolute Error (MAE), Clarke Error Grids (CEG), and Bland-Altman Plots (BAP), revealed promising outcomes, with a median MAE of 2.06 mg/dl, CEG Zone A% of 99.17%, and percentage of BAP outliers as 3.66%. While no clear correlation was found between wavelength and statistical accuracy, a significant relationship emerged between wavelength and clinical accuracy through agreement with BAP outliers. These nuanced findings highlight the potential of multispectral imaging and machine learning in advancing accurate glucose estimation.
Loading